Search

Search Constraints

You searched for: Author/Creator Heldrup, Jesper

Search Results

1. Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries. Issue 1 (18th August 2015)

2. Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. (27th October 2017)

3. Delayed elimination of high‐dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia. Issue 7 (14th December 2016)

4. Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia. Issue 8 (November 2016)

5. Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup. Issue 4 (April 2022)

6. Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing. Issue 2 (11th September 2022)

7. MTXPK.org: A Clinical Decision Support Tool Evaluating High‐Dose Methotrexate Pharmacokinetics to Inform Post‐Infusion Care and Use of Glucarpidase. Issue 3 (18th July 2020)

8. Outcome of poor response paediatric AML using early SCT. (20th January 2013)

9. Plasma creatinine as predictor of delayed elimination of high‐dose methotrexate in childhood acute lymphoblastic leukemia: A Danish population‐based study. Issue 6 (5th March 2019)

10. Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO‐AML study. Issue 8 (18th April 2014)